Cardiff Oncology Inc (CRDF)
4.20
-0.15
(-3.45%)
USD |
NASDAQ |
May 01, 16:00
4.20
0.00 (0.00%)
After-Hours: 17:55
Cardiff Oncology Cash from Operations (TTM): -30.89M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -30.89M |
| September 30, 2023 | -33.14M |
| June 30, 2023 | -32.67M |
| March 31, 2023 | -32.23M |
| December 31, 2022 | -33.82M |
| September 30, 2022 | -31.82M |
| June 30, 2022 | -29.80M |
| March 31, 2022 | -27.40M |
| December 31, 2021 | -23.04M |
| September 30, 2021 | -20.77M |
| June 30, 2021 | -18.84M |
| March 31, 2021 | -18.82M |
| December 31, 2020 | -16.32M |
| September 30, 2020 | -14.47M |
| June 30, 2020 | -14.13M |
| March 31, 2020 | -13.28M |
| December 31, 2019 | -13.27M |
| September 30, 2019 | -13.60M |
| June 30, 2019 | -13.90M |
| March 31, 2019 | -13.70M |
| December 31, 2018 | -13.20M |
| September 30, 2018 | -12.92M |
| June 30, 2018 | -16.03M |
| March 31, 2018 | -17.38M |
| December 31, 2017 | -23.28M |
| Date | Value |
|---|---|
| September 30, 2017 | -28.95M |
| June 30, 2017 | -29.40M |
| March 31, 2017 | -32.88M |
| December 31, 2016 | -31.04M |
| September 30, 2016 | -28.84M |
| June 30, 2016 | -26.94M |
| March 31, 2016 | -24.30M |
| December 31, 2015 | -22.12M |
| September 30, 2015 | -19.18M |
| June 30, 2015 | -17.45M |
| March 31, 2015 | -14.66M |
| December 31, 2014 | -12.73M |
| September 30, 2014 | -10.72M |
| June 30, 2014 | -9.405M |
| March 31, 2014 | -8.487M |
| December 31, 2013 | -7.317M |
| September 30, 2013 | -6.778M |
| June 30, 2013 | -6.098M |
| March 31, 2013 | -5.658M |
| December 31, 2012 | -4.935M |
| September 30, 2012 | -4.140M |
| June 30, 2012 | -3.115M |
| March 31, 2012 | -2.267M |
| December 31, 2011 | -1.930M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-33.82M
Minimum
Dec 2022
-13.27M
Maximum
Dec 2019
-22.75M
Average
-20.77M
Median
Sep 2021
Cash from Operations (TTM) Benchmarks
| BioVie Inc | -41.11M |
| Perspective Therapeutics Inc | -36.91M |
| Biolase Inc | -14.09M |
| Tenon Medical Inc | -12.18M |
| Adial Pharmaceuticals Inc | -6.807M |